First Documentation of In Vivo and In Vitro Ivermectin Resistance in Sarcoptes scabiei

Ivermectin is increasingly being used to treat scabies, especially crusted (Norwegian) scabies. However, treatment failures, recrudescence, and reinfection can occur, even after multiple doses. Ivermectin resistance has been documented for some intestinal helminths in animals with intensive ivermect...

Full description

Saved in:
Bibliographic Details
Published inClinical infectious diseases Vol. 39; no. 1; pp. e8 - e12
Main Authors Currie, Bart J., Harumal, Pearly, McKinnon, Melita, Walton, Shelley F.
Format Journal Article
LanguageEnglish
Published United States The University of Chicago Press 01.07.2004
Subjects
Adult
Animals
Drug Resistance - physiology
Female
Humans
Insecticides - pharmacology
Ivermectin - pharmacology
Male
Middle Aged
Sarcoptes scabiei
Sarcoptes scabiei - drug effects
Sarcoptidae
Scabies - parasitology
Online AccessGet full text

Cover

More Information
Summary:Ivermectin is increasingly being used to treat scabies, especially crusted (Norwegian) scabies. However, treatment failures, recrudescence, and reinfection can occur, even after multiple doses. Ivermectin resistance has been documented for some intestinal helminths in animals with intensive ivermectin exposure. Ivermectin resistance has also been induced in arthropods in laboratory experiments but, to date, has not been documented among arthropods in nature. We report clinical and in vitro evidence of ivermectin resistance in 2 patients with multiple recurrences of crusted scabies who had previously received 30 and 58 doses of ivermectin over 4 and 4.5 years, respectively. As predicted, ivermectin resistance in scabies mites can develop after intensive ivermectin use.
Bibliography:ark:/67375/HXZ-PP8T92Z7-9
istex:68145AB107EB81FEA7BBAF4391871CAEE138B700
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1058-4838
1537-6591
DOI:10.1086/421776